<DOC>
	<DOCNO>NCT00757367</DOCNO>
	<brief_summary>Lavage fluid ( BAL ) insert lung lobe use flexible bronchoscope . The fluid aspirate remove remain TI . It 's perform twice specific time point 12 healthy volunteer . BAL fluid analyze insulin FDKP .</brief_summary>
	<brief_title>A Trial Determine How Long Insulin FDKP ( Molecule That Forms Technosphere Particles ) Stays Lungs Healthy Individuals After Inhalation TechnosphereÂ® Insulin ( TI ) Powder Using Bronchoalveolar Lavage ( BAL )</brief_title>
	<detailed_description>Informed consent eligibility occur Screening . Dosing Visit 2 . Blood glucose level monitor adjust use IV infusion glucose . Bronchoalveolar lavage ( BAL ) perform 30 minute 6 hour Cohort 1 4 8 hour Cohort 2 , post TI dose . A series blood sample take specified timepoints . Cohort 3 proceed dose deem necessary analysis BAL Cohorts 1 &amp; 2 performed . Visit 3 follow-up safety visit .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Nonsmokers great equal 12 month Normal chest xray ( CXR ) Screening/Visit 1 Prebronchodilator FEV1 great equal 80 % Third National Health Nutrition Examination Survey ( NHANES ) III Predicted Prebronchodilator FEV1/FVC great equal LLN % NHANES III Predicted Prebronchodilator total lung capacity ( TLC ) great equal 80 % Predicted Intermountain Thoracic Society ( ITS ) Prebronchodilator Dlco ( unc ) great equal 80 % Predicted ( Miller ) Written Informed Consent History diabetes mellitus Previous exposure TI Inhalation Powder within 3 month Visit 1 , exposure inhaled insulin product Allergy know hypersensitivity insulin drug use trial history hypersensitivity TI Inhalation Powder drug similar chemical structure . History chronic obstructive pulmonary disease ( COPD ) , asthma , clinically important pulmonary disease ( eg , cystic fibrosis , bronchiectasis , and/or sleep apnea ) confirm PFTs and/or radiologic finding . Known allergic adverse reaction specify medication Seizure disorder , significant cardiovascular dysfunction and/or history within 3 month Visit 1 , uncontrolled hypertension , know history aortic cerebral aneurysm , renal dysfunction disease , serum creatinine &gt; 2.0 mg/dL male &gt; 1.8 mg/dL female and/or blood urea nitrogen ( BUN ) &gt; 50 mg/dL Cancer ( excise cutaneous basal cell carcinoma ) within past 5 year history lung neoplasm . History active viral and/or cirrhotic hepatic disease and/or abnormal liver enzyme , evidence serum aspartate aminotransferase ( AST ) , and/or alanine aminotransferase ( ALT ) ? 3x upper limit normal ( ULN ) . Active infection ( eg , human immunodeficiency virus ( HIV ) , hepatitis ) history severe infection within 30 day Visit 1 Anemia ( hemoglobin value ? 10.5 g/dL female ? 11.5 g/dL male . Diagnosis systemic autoimmune collagen vascular disease require previous current treatment systemic corticosteroid , cytotoxic drug , penicillamine . Current previous chemotherapy , radiation therapy , amiodarone use may result pulmonary toxicity . Clinically significant abnormality screen laboratory evaluation ( unless approve Medical Monitor ) . Female subject pregnant , lactating , plan become pregnant clinical trial period . Female subject childbearing potential practicing adequate birth control . Current drug alcohol abuse history drug alcohol abuse , , opinion PI , would make subject suitable candidate participation clinical trial . Exposure investigational medication device within previous 30 day prior trial entry participation another clinical trial participate clinical trial . Unable and/or unlikely comprehend and/or follow trial protocol . Unable and/or unlikely comprehend use MedTone Inhaler Model D inability properly use device . A lack compliance medication procedure , , PI 's opinion , may affect clinical trial data subject 's safety precludes subject participation clinical trial Any concurrent medical major psychiatric condition , opinion PI , make subject unsuitable clinical trial , could limit validity inform consent , and/or impair subject 's ability participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Healthy subject</keyword>
	<keyword>insulin</keyword>
	<keyword>bronchoscope</keyword>
	<keyword>serum insulin</keyword>
	<keyword>serum C-Peptide</keyword>
	<keyword>BAL fluid</keyword>
	<keyword>FDKP</keyword>
</DOC>